Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 7, 2020; 26(29): 4261-4271
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4261
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4261
Table 3 Memorial Sloan Kettering T stage for hilar cholangiocarcinoma
| Stage | Criteria |
| T1 | Tumor involving biliary confluence and/or unilateral extension to second-order biliary tracts |
| T2 | T1 and/or ipsilateral portal vein involvement and/or ipsilateral hepatic lobar atrophy |
| T3 | Tumor involving biliary confluence, the biliary extension to second-order biliary tracts; or unilateral extension to second-order biliary tracts with contralateral portal vein involvement; or unilateral extension to second-order radicals with contralateral hepatic lobar atrophy; or main or bilateral portal vein involvement |
- Citation: Inchingolo R, Maino C, Gatti M, Tricarico E, Nardella M, Grazioli L, Sironi S, Ippolito D, Faletti R. Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma. World J Gastroenterol 2020; 26(29): 4261-4271
- URL: https://www.wjgnet.com/1007-9327/full/v26/i29/4261.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i29.4261